People with Chronic Obstructive Pulmonary Disease (COPD) Who Received Nutrition Treatment in the Hospital Had Better Health Outcomes
New research in the international medical journal CHEST showed patients had reduced hospital stays, medical costs and returns to the hospital
ABBOTT PARK, Ill., Nov. 17, 2014 /PRNewswire/ -- People aged 65 and older, who were being treated for chronic obstructive pulmonary disease (COPD) in the hospital and received nutrition treatment (oral nutrition supplements) had reduced lengths of stay, hospital costs and chances of returning to the hospital within 30-days, according to a study published in CHEST.1
Chronic obstructive pulmonary disease (COPD) — which includes conditions like chronic bronchitis and emphysema — is a lung disease that compromises breathing. As COPD often occurs among seniors, it is one of the leading causes of disability and death in the U.S. and has been estimated to cost $50 billion per year.2
Nutrition Treatment Shows Better Outcomes
The study, which was supported by Abbott, evaluated Medicare patients, 65 and older, who were hospitalized with a primary diagnosis of COPD. The study demonstrates that when older patients with COPD received nutrition treatment in the hospital, it reduced their length of stay by 1.88 days (21.5 percent) and total hospital costs by $1,570 (12.5 percent) on average, compared to those who did not receive nutrition treatment. When looking at the likelihood of readmission within 30 days, the people who received nutrition treatment had a 13.1 percent reduction in 30-day readmission.
"Our findings suggest that screening seniors in the hospital for malnutrition risk and providing cost-effective treatment for those who are malnourished or at risk, can have a positive health impact on outcomes," said Julia Thornton Snider, Ph.D., at Precision Health Economics and lead author for the study. "In addition, our new readmission data suggests economic benefits for the hospital, including how they may better achieve the new Medicare mandates for reducing readmission rates in elderly COPD patients."
This year, Medicare will raise its maximum penalty for hospitals that have too many patients readmitted within 30-days. The program, part of the Affordable Care Act, typically calculates this number by looking at readmissions of patients who had a heart attack, heart failure and pneumonia. Beginning in 2015 Medicare will examine readmissions of total hip/knee replacements and patients with COPD. Medicare patients with COPD already incur roughly $20,500 more in healthcare costs than those without.3
Impact of Poor Nutrition on People with COPD
Those with COPD are at a higher risk of being malnourished, which can weaken their strength and immune system and cause complications during recovery.4,5
Despite the nutritional need for people with COPD and the fact that it's the third leading cause of death in the U.S., current guidelines do not include any specific recommendations for addressing nutritional deficiencies in this group.6 However, researchers are working to change this as a growing number of studies are being published that show the economic and health benefits that nutrition screenings and treatment has on COPD as well as other health issues.
"Abbott has been partnering with leading research institutions to better understand how we can improve health outcomes of people affected by certain conditions," said Robert H. Miller, Ph.D., Divisional Vice President, R&D, Scientific and Medical Affairs, at Abbott Nutrition. "By identifying solutions, such as oral nutritional supplements, we may be able to help people with COPD have better health results and reduce healthcare costs."
Additional information on the study, including authors and affiliation, can be found at www.chestnet.org.
About Abbott
Abbott (NYSE: ABT) is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 69,000 people.
Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.
References:
1 Snider, J. et al. Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD. CHEST. 2014; published online 30 October 2014. DOI: 10.1378/chest.14-1368.
2 Robinson AB, Stogsdill JA, Lewis JB, Wood TT, Reynolds PR. RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease. Front Physiol.2012;3:301.
3 Menzin J, Boulanger L, Marton J, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. Respir Med. 2008;102(9):1248-1256.
4 Aniwidyaningish W, Varraso R, Cano N, Pison C. Impact of nutritional status on body functioning in chronic obstructive pulmonary disease and how to intervene. Curr Opin Clin Nutr Metab Care. 2008; 11(4): 435–442.
5 Ezzell L, Jensen GL. Malnutrition in chronic obstructive pulmonary disease. Am J Clin Nutr. 2000; 72(6): 1415-1416
6 Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. Aug 2 2011; 155(3):179-191.
Photo - http://photos.prnewswire.com/prnh/20141113/158619-INFO
SOURCE Abbott
Share this article